Payment overview · 2025
General Payments
$67.44
3 reported records · 3 companies
Healthcare provider profile · identity verified
Jonathon Lex Park, MD
Allopathic & Osteopathic Physicians|Family Medicine · BANDON, OR · NPI 1588649289
Verified facts
What the public records show
CMS Open Payments records show Jonathon Lex Park, MD received $67.44 in general payments during 2025 across 3 reported records.
AstraZeneca Pharmaceuticals LP accounted for 47.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Synthroid by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $31.98 | 47.4% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $21.30 | 31.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.16 | 21.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.46 | 2 |
| Education | $31.98 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $31.98 | 1 | 2025 |
Source payment records
|
|||||
| MAVYRET Normalized: mavyret |
Drug | ABBVIE INC. | $21.30 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $14.16 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Losartan Potassium | Losartan Potassium | 591 | 162 |
| Lisinopril | Lisinopril | 512 | 141 |
| Amlodipine Besylate | Amlodipine Besylate | 506 | 142 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 459 | 134 |
| Atorvastatin Calcium | Atorvastatin Calcium | 389 | 113 |
| Levothyroxine Sodium | Levothyroxine Sodium | 366 | 99 |
| Metoprolol Succinate | Metoprolol Succinate | 357 | 99 |
| Omeprazole | Omeprazole | 330 | 88 |
| Gabapentin | Gabapentin | 278 | 75 |
| Potassium Chloride | Potassium Chloride | 252 | 63 |
| Pravastatin Sodium | Pravastatin Sodium | 245 | 67 |
| Furosemide | Furosemide | 244 | 67 |
| Metformin Hcl | Metformin Hcl | 234 | 67 |
| Hydrochlorothiazide | Hydrochlorothiazide | 228 | 61 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 201 | 46 |
| Carvedilol | Carvedilol | 196 | 48 |
| Simvastatin | Simvastatin | 173 | 50 |
| Citalopram Hbr | Citalopram Hydrobromide | 150 | 44 |
| Eliquis | Apixaban | 149 | 38 |
| Lorazepam | Lorazepam | 137 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 131 | 49 |
| Ezetimibe | Ezetimibe | 118 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 118 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 117 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 117 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 114 | 29 |
| Sertraline Hcl | Sertraline Hcl | 114 | 23 |
| Pantoprazole Sodium | Pantoprazole Sodium | 113 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 30 |
| Montelukast Sodium | Montelukast Sodium | 111 | 28 |
| Donepezil Hcl | Donepezil Hcl | 110 | 25 |
| Warfarin Sodium | Warfarin Sodium | 109 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 103 | 22 |
| Alendronate Sodium | Alendronate Sodium | 100 | 29 |
| Famotidine | Famotidine | 97 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 96 | 34 |
| Allopurinol | Allopurinol | 94 | 23 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 92 | 50 |
| Trazodone Hcl | Trazodone Hcl | 91 | 24 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 85 | 66 |
| Meloxicam | Meloxicam | 79 | 27 |
| Ozempic | Semaglutide | 77 | 13 |
| Tramadol Hcl | Tramadol Hcl | 77 | 24 |
| Januvia | Sitagliptin Phosphate | 76 | 13 |
| Jardiance | Empagliflozin | 75 | 18 |
| Baclofen | Baclofen | 74 | 14 |
| Metformin Hcl Er | Metformin Hcl | 74 | 20 |
| Spironolactone | Spironolactone | 72 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 71 | 21 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 66 | 14 |
| Pregabalin | Pregabalin | 65 | 16 |
| Atenolol | Atenolol | 63 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 60 | 19 |
| Glipizide Er | Glipizide | 60 | 16 |
| Glimepiride | Glimepiride | 59 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | 13 |
| Alprazolam | Alprazolam | 57 | suppressed |
| Glipizide | Glipizide | 54 | 13 |
| Lovastatin | Lovastatin | 50 | 15 |
| Amoxicillin | Amoxicillin | 49 | 35 |
| Bupropion Xl | Bupropion Hcl | 47 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | suppressed |
| Xarelto | Rivaroxaban | 47 | suppressed |
| Eszopiclone | Eszopiclone | 46 | 12 |
| Finasteride | Finasteride | 46 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 46 | 20 |
| Prednisone | Prednisone | 45 | 29 |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 24 |
| Estradiol | Estradiol | 43 | 16 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 41 | 39 |
| Memantine Hcl | Memantine Hcl | 41 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 40 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 38 | suppressed |
| Cephalexin | Cephalexin | 38 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 38 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 37 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 37 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 36 | 11 |
| Celecoxib | Celecoxib | 35 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 25 |
| Digoxin | Digoxin | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | suppressed |
| Clonazepam | Clonazepam | 31 | suppressed |
| Topiramate | Topiramate | 30 | suppressed |
| Gemfibrozil | Gemfibrozil | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 26 | 21 |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Nystatin | Nystatin | 26 | 16 |
| Ibuprofen | Ibuprofen | 25 | suppressed |
| Methocarbamol | Methocarbamol | 25 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 25 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 25 | 12 |
| Telmisartan | Telmisartan | 24 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 23 | suppressed |
| Nifedipine Er | Nifedipine | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 22 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 22 | 13 |
| Torsemide | Torsemide | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 15 |
| Folic Acid | Folic Acid | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 11 |
| Ketoconazole | Ketoconazole | 17 | 15 |
| Latanoprost | Latanoprost | 17 | suppressed |
| Fluconazole | Fluconazole | 16 | 11 |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 13 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Buprenorphine | Buprenorphine | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Dulera | Mometasone/Formoterol | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Ramelteon | Ramelteon | 14 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Entacapone | Entacapone | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 11 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $67.44 · 3 records | AstraZeneca Pharmaceuticals LP | BREZTRI, EVENITY, MAVYRET | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error